Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Role of Topically Dissolved Oxygen (TDO) to Ameliorate Signs of Photodamage in Individuals With Multiple Skin Conditions A Double-Blind, Placebo Controlled Comparative Trial

NCT00991198 is registered in ClinicalTrials.gov with Aria Aesthetics Inc. as lead sponsor.

NCT NCT00991198
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00991198 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Role of Topically Dissolved Oxygen (TDO) to Ameliorate Signs of Photodamage in Individuals With Multiple Skin Conditions A Double-Blind, Placebo Controlled Comparative Trial
Lead sponsor
Aria Aesthetics Inc.
Phase
Phase 2
Overall status
Completed
Start date
September 30, 2009
Completion date
January 31, 2010
Enrollment
49 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

acne vulgaris, atopic dermatitis, rosacea, seborrheic dermatitis